You are here: Industry Insights > cell line

News List

Optimizing Biotherapeutic Production: The Power of Cell Line Engineering Shruti Talashi
August 01, 2024
Cell line development has emerged as a cornerstone in the biopharmaceutical industry.
Celonic Launches New GS-CHOvolution® Cell Line Expression System PharmaSources
April 10, 2024
GS-CHOvolution® is based on Revvity’s CHOSOURCE™ expression platform and TnT transposon technology.
GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development B3C newswire
November 06, 2023
ProBioGen and GeoVax Labs, announce the signing of a landmark commercial license agreement for ProBioGen's groundbreaking AGE1.
Genomic Vision Launches HexaCard, a New Service to CharacterizeCell Lines Used for Biomanufacturing and Cell & Gene Therapy PharmaSources
July 18, 2023
Genomic Vision Launches HexaCard, a New Service to CharacterizeCell Lines Used for Biomanufacturing and Cell & Gene Therapy.
ProBioGen Launches Their Lentivirus Packaging Cell Line Lenti.RiGHT - A Shortcut to Successful Lentivirus Manufacturing PharmaSources
May 18, 2023
May 17, 2023，ProBioGen announced the launch of their lentivirus (LV) packaging cell line Lenti.RiGHT as a new platinum standard for LV production at this year's PEGS Boston 2023.
Cell line development services market to value $2.4 billion by 2030 europeanpharmaceuticalreview
August 11, 2021
New report suggests the cell line development services market will witness a 14.3 percent CAGR between 2021 and 2030.
ValenzaBio, ProBioGen Enter Cell Line Pact contractpharma
July 29, 2021
ProBioGen and ValenzaBio have initiated a cell line development project involving the application of ProBioGen's GlymaxX technology.
ValenzaBio Partners with ProBioGen to Maximize Cell Line Productivity and Licenses GlymaxX® b3cnewswire
July 28, 2021
ProBioGen and ValenzaBio today jointly announced the initiation of a cell line development project involving the application of ProBioGen's proprietary GlymaxX technology.
Catalent Biologics Launches GPEx Lightning Cell Line Expression Technology contractpharma
July 23, 2021
Designed to shorten drug substance development timelines by up to three months.
Heat Biologics Enters into Research License Agreement for ProBioGen's Transposase System and Suspension HEK293 Cell Line b3cnewswire
July 14, 2021
ProBioGen announced today that they have entered into a research license agreement with Heat Biologics for both ProBioGen's Transposase System DirectedLuck™ as well as for their proprietary suspension HEK293 cell line.